Name of the product: VIRAINHI

Active ingredient: Nevirapine 200 mg

Dosage form: tablets

Dispensing requirements: Rx only

Argentine Industry

Composition:

Each tablet contains nevirapine 200 mg, lactose, sodium starch glycolate, colloidal silicium dioxide and magnesium estearate.

Indications:

VIRAINHI in combination with other nucloeoside analogue reverse transcriptase inhibitors is indicated for the treatment of HIV-1 infection in adult patients who have clinical and/or immunologic impairment.

Therapeutic action:

Antiretroviral.

Storage:

Keep at temperature between 15º and 30º C in the marketed packing.

Marketed presentations:

Packs containing 60 and 100 tablets.

Medicinal speciality authorised by the Ministry of Health.

Certificate Nº 49540

Laboratorio DOSA S.A.

Girardot 1369, (C1427AKC) Buenos Aires, Argentine

Pharmaceutical Director: María C. Terzo, Pharmacist